Eurofins BioPharma Product Testing Denmark Holding A/S — Credit Rating and Financial Key Figures
CVR number: 37064408
Smedeskovvej 38, 8464 Galten
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -79.99 | -84.05 | -87.65 | -92.64 | - 103.88 |
| EBIT | -79.99 | -84.05 | -87.65 | -92.64 | - 103.88 |
| Other financial income | 0.47 | 0.91 | 11.50 | 99.69 | 186.63 |
| Other financial expenses | -2 135.25 | -2 091.44 | -2 615.74 | -3 717.11 | -3 643.32 |
| Reduction non-current investment assets | -3 000.00 | - 100.00 | |||
| Net income from associates (fin.) | 7 000.00 | 6 000.00 | 10 000.00 | 9 500.00 | 1 000.00 |
| Pre-tax profit | 4 785.23 | 3 825.42 | 7 308.11 | 2 789.94 | -2 660.57 |
| Income taxes | 487.25 | 478.41 | 592.22 | 816.21 | 783.33 |
| Net earnings | 5 272.48 | 4 303.83 | 7 900.33 | 3 606.15 | -1 877.24 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 58 000.00 | 58 000.00 | 58 000.00 | 58 000.00 | 57 900.00 |
| Investments total | 58 000.00 | 58 000.00 | 58 000.00 | 58 000.00 | 57 900.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 3 386.63 | 2 692.02 | 6 526.04 | 7 730.64 | 4 078.00 |
| Current deferred tax assets | 487.25 | 478.41 | 592.22 | 816.21 | 783.33 |
| Short term receivables total | 3 873.88 | 3 170.42 | 7 118.26 | 8 546.86 | 4 861.32 |
| Balance sheet total (assets) | 61 873.88 | 61 170.42 | 65 118.26 | 66 546.85 | 62 761.32 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Shares repurchased | 5 000.00 | 4 300.00 | 5 300.00 | 1 800.00 | |
| Retained earnings | 5 125.10 | 6 097.58 | 5 101.41 | 14 201.74 | 17 807.89 |
| Profit of the financial year | 5 272.48 | 4 303.83 | 7 900.33 | 3 606.15 | -1 877.24 |
| Shareholders equity total | 15 897.58 | 15 201.41 | 18 801.74 | 20 107.89 | 16 430.65 |
| Provisions | 0.00 | ||||
| Non-current owed to group member | 45 431.35 | 45 431.35 | 45 431.35 | 45 431.35 | 45 431.35 |
| Non-current liabilities total | 45 431.35 | 45 431.35 | 45 431.35 | 45 431.35 | 45 431.35 |
| Current trade creditors | 16.88 | 27.00 | |||
| Current owed to participating | 537.67 | ||||
| Current owed to group member | 531.75 | 537.67 | 870.77 | 990.74 | 872.33 |
| Other non-interest bearing current liabilities | 13.20 | 14.40 | |||
| Current liabilities total | 544.95 | 1 075.33 | 885.17 | 1 007.62 | 899.33 |
| Balance sheet total (liabilities) | 61 873.88 | 61 708.09 | 65 118.26 | 66 546.85 | 62 761.32 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.